Welcome to the first in our new series of sector-specific regulatory roundups. This edition focuses on health regulation in New Zealand, where vaping reforms, system reviews and medicine safety updates are reshaping the regulatory landscape. We’ll be publishing regular sector-by-sector updates from across the region to keep you informed and ahead.
From prescription reform to a vape crackdown, New Zealand’s health sector is undergoing one of its most active periods of regulatory change in recent years. New rules are reshaping how care is accessed, how products are sold and marketed, and how system performance is measured.
At the centre of this transition is a push for greater accountability and regulatory clarity, whether in the setting of immunisation targets, the issuing of safety alerts, or the entry of international medical graduates into the workforce. The result is a more assertive health regulatory environment, with implications for providers, patients, and regulators alike.
That same assertiveness is evident in the government’s approach to vaping, a sector now subject to some of the country’s most restrictive product and marketing rules to date.
Vape crackdown takes effect
A ban on disposable vapes came into force across New Zealand on 17 June, part of a broader push to curb youth vaping and reduce electronic waste.
The new rules prohibit the sale of single-use vaping devices that cannot be recharged or refilled. Retailers found in breach face fines of up to $2,000. The move follows data from the 2023/24 NZ Health Survey showing that over 10% of teens between 15 and 17 years old vape daily.
Accompanying the product ban are sweeping advertising restrictions. General retailers may no longer display vape products in-store, while specialist vape shops must ensure merchandise is not visible from the street. Online, all forms of advertising – including social media posts and promotional offers – are now banned. Loyalty schemes, giveaways, and discounts are also prohibited.
While refillable pod-based devices remain legal, public health experts have welcomed the reforms as a measured step to limit youth access and reduce normalisation of vaping. The Ministry of Health says the disposable vape ban will cut vape-related e-waste by more than 80%. Retailers are being urged to review compliance procedures, particularly across online channels and store displays, as regulators begin enforcing the new regime.
With single-use vapes now off the shelves, regulators are clearing the air on both youth access and environmental impact.
Health reform legislation shifts focus to performance and outcomes
Cabinet recently approved sweeping amendments to the Pae Ora (Healthy Futures) Act 2022, placing health system performance and accountability at the centre of the regulatory framework.
The changes will enshrine national targets in law, require all health strategies to give effect to them, and assign Health New Zealand a new statutory role in infrastructure delivery, supported by a dedicated Health Infrastructure Board. Local Iwi–Māori Partnership Boards will refocus their efforts toward informing a national advisory committee rather than designing local services.
The emphasis on measurable outcomes is already shaping interim actions. The government reports that nearly 10,000 additional elective surgeries have been delivered through private hospitals to ease public waitlists. Meanwhile, officials are considering extending childhood vaccination programmes such as free meningococcal B immunisation, following signs of declining immunisation rates.
These operational decisions reflect a shift toward legislated performance, which will be formalised in the forthcoming Pae Ora amendment bill. The government says the goal is to reduce administrative complexity and improve transparency and delivery across the public health system. What emerges is a health system less focused on structure for its own sake and more on what it actually delivers.
Prescription reform extends renewal window
Brown also recently announced changes that will allow 12-month prescription renewals for stable patients starting early 2026. The reform extends the current three-month limit and targets long-term conditions such as diabetes and hypertension. It will require amendments to the Medicines Regulations 1984 and sector-wide IT updates. Health NZ and Pharmac are coordinating the shift, while the Pharmaceutical Society has flagged concerns about pharmacy workloads.
These developments reflect a visible shift toward outcome-driven regulation. The move to legislate performance targets under Pae Ora, restrict retail and digital marketing for vapes, and tighten oversight on pharmaceuticals all signal a more structured and measurable approach to public health governance.
Registration exam limits create bottleneck for international doctors
Pressure is mounting on the medical workforce pipeline as entry exams for international doctors hit full capacity. Both upcoming sittings of the New Zealand Registration Examination (NZREX Clinical) have reached capacity, according to the Medical Council. No further applications will be accepted for the June or September 2025 sessions. The exam is a critical pathway for internationally trained doctors seeking to practise in New Zealand. The 2026 schedule will be released later this year.
A system under review – and under pressure to perform
What unites these developments is a visible shift toward outcome-driven regulation. The move to legislate performance targets under Pae Ora, restrict retail and digital marketing for vapes, and tighten oversight on pharmaceuticals all signal a more structured and measurable approach to public health governance.
For regulators, the challenge now lies in maintaining pace with these reforms while ensuring implementation remains coordinated, transparent and responsive. As New Zealand’s health system continues to evolve, its regulatory infrastructure will need to adapt just as quickly, not only to enforce new rules, but to anticipate what comes next.
Subscribe to The Modern Regulator to stay ahead of the latest in health sector regulation, from legislative reform to product safety and beyond.
